Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Return on Invested Capital (2016 - 2026)

Champions Oncology (CSBR) has 15 years of Return on Invested Capital data on record, last reported at 0.58% in Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 482.0% year-over-year to 0.58%; the TTM value through Oct 2025 reached 0.58%, up 482.0%, while the annual FY2025 figure was 4.95%, 1031.0% up from the prior year.
  • Return on Invested Capital reached 0.58% in Q4 2025 per CSBR's latest filing, down from 0.76% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 9.85% in Q1 2024 and bottomed at 9.58% in Q4 2023.
  • Average Return on Invested Capital over 5 years is 0.18%, with a median of 0.05% recorded in 2021.
  • Peak YoY movement for Return on Invested Capital: crashed -960bps in 2023, then surged 1023bps in 2024.
  • A 5-year view of Return on Invested Capital shows it stood at 0.05% in 2021, then crashed by -60bps to 0.02% in 2022, then tumbled by -49347bps to 9.58% in 2023, then surged by 56bps to 4.25% in 2024, then surged by 114bps to 0.58% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.58% in Q4 2025, 0.76% in Q3 2025, and 1.0% in Q2 2025.